Related Experiment Video
Updated: Jul 16, 2026

05:31
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.8K
[Testing for latent tuberculosis infection needs to be improved in Denmark]
Anne Christine Nordholm1, Pernille Ravn, Kristina Langholz Kristensen
1anch@ssi.dk.
Ugeskrift for Laeger
|December 4, 2019
Summary
Tuberculosis (TB) is a global health issue. Increasing awareness and diagnosis of latent TB infection (LTBI) in Denmark can help prevent active TB cases, especially in high-risk individuals.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) poses a significant global public health challenge.
- The World Health Organization (WHO) advocates for increased awareness of latent tuberculosis infection (LTBI) in low-incidence countries as a preventive measure.
- Denmark, as a low-incidence country, can benefit from enhanced strategies for TB prevention.
Purpose of the Study:
- To review the burden of TB in Denmark.
- To emphasize the importance of diagnosing LTBI in at-risk populations.
- To advocate for initiating LTBI treatment to prevent the progression to active TB.
Main Methods:
- This study is a review of existing literature and data on TB in Denmark.
- It focuses on identifying patient groups who would benefit from LTBI testing and treatment.
- Analysis of risk factors and comorbidities associated with TB development.
Main Results:
- The burden of TB in Denmark could be reduced through improved LTBI diagnosis and treatment.
- Targeted LTBI testing is crucial for individuals at risk of developing active TB.
- Prompt treatment of LTBI can prevent future active TB cases.
Conclusions:
- Increased focus on diagnosing and treating latent TB infection is recommended for Denmark.
- LTBI testing should be prioritized for individuals with recent infection, organ transplant recipients, and those with comorbidities like HIV, undergoing dialysis, or with immunosuppression.
- Proactive management of LTBI is key to reducing the overall TB burden.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

